Skip to main content
OpenTrials

Clinical trial condition

Lung Diseases, Obstructive

Explore clinical trials studying Lung Diseases, Obstructive. Study availability and eligibility vary by location and protocol.

7,996 public trials 744 recruiting studies
Refine in advanced search Browse all conditions

Lung Diseases, Obstructive trial results

Completed

National Validation and Sensitivity to Change of the SAQ

NCT04031261

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +7 more
Locations
  • Birmingham Heartlands Hospital Birmingham, United Kingdom
  • Royal Devon & Exeter Hospital Exeter, United Kingdom
  • Royal Brompton Hospital London, United Kingdom
  • Wythenshawe Hospital - Manchester Manchester, United Kingdom
View Trial Details
Completed

A Safety, Tolerability and Efficacy Study With QBW251 in COPD Patients With QBW251

NCT02449018

Conditions
Bronchial Diseases, Bronchitis, Bronchitis, Chronic, +12 more
Locations
  • Novartis Investigative Site Birmingham, Alabama, United States
  • Novartis Investigative Site Fullerton, California, United States
  • Novartis Investigative Site Waterbury, Connecticut, United States
  • Novartis Investigative Site Clearwater, Florida, United States
View all 16 locations
View Trial Details
Completed

Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.

NCT03257995

Conditions
Asthma, Bronchial Diseases, Dyspnea, +11 more
Locations
  • Novartis Investigative Site North Dartmouth, Massachusetts, United States
  • Novartis Investigative Site St Louis, Missouri, United States
  • Novartis Investigative Site Skillman, New Jersey, United States
  • Novartis Investigative Site Raleigh, North Carolina, United States
View Trial Details
Completed

QVA Mechanistic Efficacy Study (Receptor Effects, Etc)

NCT02634983

Conditions
Behavior, Chronic Disease, Chronic Obstructive Pulmonary Disease, +9 more
Locations
  • Novartis Investigative Site Sheffield, South Yorkshire, United Kingdom
  • Novartis Investigative Site Bradford, West Yorkshire, United Kingdom
  • Novartis Investigative Site Manchester, United Kingdom
View Trial Details
Completed

Assess Bronchodilator Effect QVM149 Dosed Either in the Morning or Evening Compared to Placebo in Patients With Asthma

NCT03108027

Conditions
Asthma, Bronchial Diseases, Dyspnea, +11 more
Locations
  • Novartis Investigative Site Berlin, Germany
  • Novartis Investigative Site Frankfurt Am Main Hessen, Germany
  • Novartis Investigative Site Großhansdorf, Germany
  • Novartis Investigative Site Hanover, Germany
View Trial Details
Completed

Dose-finding Study of QGE031 as add-on Therapy to Evaluate Efficacy and Safety in Patients With CSU

NCT02477332

Conditions
Bronchial Diseases, Bronchiolitis, Bronchiolitis Obliterans, +20 more
Locations
  • Novartis Investigative Site Birmingham, Alabama, United States
  • Novartis Investigative Site Scottsdale, Arizona, United States
  • Novartis Investigative Site Little Rock, Arkansas, United States
  • Novartis Investigative Site Huntington Beach, California, United States
View all 82 locations
View Trial Details
Completed

Evaluating Anatomic Versus Targeted Lead Placement for Burst Stimulation Therapy During the Trial

NCT03277378

Conditions
Bronchial Diseases, Bronchiolitis, Bronchiolitis Obliterans, +9 more
Locations
  • Jason Edward Pope, MD Santa Rosa, California, United States
  • Comprehensive Spine Institute Clearwater, Florida, United States
  • Florida Pain Institute Merritt Island, Florida, United States
  • National Pain Institute Winter Park Winter Park, Florida, United States
View all 25 locations
View Trial Details
Completed

Early Detection of COPD Patients in GOLD 0 (Smokers) Population

NCT01550679

Conditions
Behavior, COPD, Chronic Disease, +9 more
Locations
  • University Hospital Osijek Osijek, Slavonsko-Baranjska, Croatia
  • General Hospital Dubrovnik Dubrovnik, Croatia
  • University Hospital Rijeka Rijeka, Croatia
  • Clinical Hospital Center, Split Split, Croatia
View Trial Details

Related conditions